Add-on Acquisition • Life Science

Teva Pharmaceutical Industries Acquires Merckle

On August 10, 2010, Teva Pharmaceutical Industries acquired life science company Merckle

Acquisition Context
  • This is Teva Pharmaceutical Industries’ 10th transaction in the Life Science sector.
  • This is Teva Pharmaceutical Industries’ 2nd transaction in Germany.

Explore All 3111 Add-on Acquisition Life Science Deals - Search the Database Free


M&A Deal Summary

Date August 10, 2010
Target Merckle
Sector Life Science
Buyer(s) Teva Pharmaceutical Industries
Deal Type Add-on Acquisition

Target Company

Merckle

Blaubeuren, Germany
Merckle GmbH engages in research, development, production, and marketing of pharmaceutical products in Europe.
Explore More Deals

Browse All 215,158 Deals

FILTER BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Search Free

Buyer Overview 1

Buyer

Teva Pharmaceutical Industries

Tel Aviv, Israel

Category Company
Founded 1901
Sector Life Science
Employees37,000
Revenue 16.5B USD (2024)
DESCRIPTION

Teva Pharmaceutical Industries is a provider of pharmaceutical products, committed to increasing access to high-quality healthcare by developing, producing, and marketing affordable generic drugs as well as innovative and specialty pharmaceuticals and active pharmaceutical ingredients. Teva Pharmaceutical Industries was founded in 1901 and is based in Tel Aviv, Israel.


Deal Context for Buyer #
Overall 11 of 23
Sector: Life Science 10 of 20
Type: Add-on Acquisition 10 of 19
Country: Germany 2 of 2
Year: 2010 2 of 3
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2010-03-18 ratiopharm

Ulm, Germany

ratiopharm GmbH is a developer, manufacturer, distributor, and sells generic medicines and biopharmaceuticals.

Buy €3.6B
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2010-10-28 Thermamex

London, United Kingdom

Theramex is a global specialty pharmaceutical company dedicated to women and their health. The Company markets a broad range of branded and branded generic products across 50 countries around the world. The portfolio, which is dedicated to women's health, focuses on contraception, fertility, menopause and osteoporosis and includes key brands such as Ovaleap®, Zoely®, Seasonique®, Actonel®, Estreva® and Lutenyl®. Thermamex is based in London, United Kingdom.

Buy €265M